Nantahala Capital Management’s Aura Biosciences AURA Stock Holding History

Nantahala Capital Management’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.2M	Hold	2,117,697	–	–	0.52%	52
2025 Q4	$11.5M	Hold	2,117,697	–	–	0.38%	61
2025 Q3	$13.1M	Hold	2,117,697	–	–	0.45%	51
2025 Q2	$13.3M	Buy	2,117,697 +850,000	+67%	+$4.97M	0.52%	43
2025 Q1	$7.43M	Sell	1,267,697 -2,338	-0.2%	-$17.7K	0.3%	53
2024 Q4	$10.4M	Hold	1,270,035	–	–	0.45%	45
2024 Q3	$11.3M	Hold	1,270,035	–	–	0.57%	35
2024 Q2	$9.6M	Sell	1,270,035 -51,825	-4%	-$380K	0.56%	35
2024 Q1	$10.4M	Hold	1,321,860	–	–	0.59%	34
2023 Q4	$11.7M	Buy	1,321,860 +577,968	+78%	+$4.89M	0.7%	28
2023 Q3	$6.67M	Sell	743,892 -59,433	-7%	-$639K	0.57%	41
2023 Q2	$9.92M	Sell	803,325 -40,121	-5%	-$429K	0.96%	26
2023 Q1	$7.83M	Buy	843,446 +44,695	+6%	+$464K	0.6%	38
2022 Q4	$8.39M	Buy	798,751 +414,987	+108%	+$5.28M	0.54%	39
2022 Q3	$6.95M	Buy	383,764 +40,549	+12%	+$614K	0.45%	49
2022 Q2	$4.86M	Buy	343,215 +41,225	+14%	+$682K	0.24%	63
2022 Q1	$6.64M	Buy	301,990 +202,844	+205%	+$3.86M	0.29%	58
2021 Q4	$1.68M	Buy	+99,146	New	+$1.77M	0.06%	111

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nantahala Capital Management's AURA Position: Q1 2026 in Review

Nantahala Capital Management held its Aura Biosciences (AURA) position steady in Q1 2026 at 2,117,697 shares worth $14.2M. The position accounts for 0.52% of the portfolio, ranked #52.

Nantahala Capital Management first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

Nantahala Capital Management held 2,117,697 shares of Aura Biosciences worth $14.2M as of Q1 2026.
Nantahala Capital Management left its Aura Biosciences share count unchanged in Q1 2026.
Aura Biosciences made up 0.52% of Nantahala Capital Management's portfolio in Q1 2026, its #52 holding.
Nantahala Capital Management first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.